Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Positive Opinion for Merck's Elonva
Yahoo/Zacks.com
Monday, November 23, 2009 - 3:39pm
tags:
Merck, Elonva, fertility drugs
CytRx: Technical Breakout Imminent
Seeking Alpha
Monday, November 23, 2009 - 10:20am
tags:
CytRx
Raptor Pharma's NGX426 For Pain Relief Proves Effective In Test
RTT News
Monday, November 23, 2009 - 10:19am
tags:
Raptor Pharmaceuticals, neuropathic pain, drug trials
A Big Upgrade for Allos Therapeutics
Motley Fool
Monday, November 23, 2009 - 10:17am
tags:
Allos
Drug stocks advance; Cephalon falls on study
Marketwatch
Monday, November 23, 2009 - 10:13am
tags:
Cephalon, drug stocks
Encouraging Data on J&J's Simponi
Yahoo/Zacks.com
Monday, November 23, 2009 - 10:09am
tags:
Simponi, rheumatoid arthritis, JNJ
GlaxoSmithKline Withdraws Avodart US New Drug Application
WSJ Online
Monday, November 23, 2009 - 9:52am
tags:
Avodart, prostate cancer, GSK, sNDA
Good News for Bristol-Myers
Yahoo/Zacks.com
Monday, November 23, 2009 - 9:49am
tags:
Abilify, Bristol-Myers Squibb, JNJ, AstraZeneca, autism
CMS Moves Up Avastin Pricing Changes
Pharmalot
Monday, November 23, 2009 - 9:37am
tags:
Avastin, CMS, Medicare, Medicaid, macular degeneration
Icahn Makes Big Moves in Healthcare Stocks
Yahoo/Indie Research
Monday, November 23, 2009 - 9:34am
tags:
Genzyme, Carl Icahn, Biogen Idec, Amylin
Abbott: FDA Issues New Obesity Drug Heart Warning
TheStreet.com
Monday, November 23, 2009 - 9:20am
tags:
obesity, Abbott Laboratories, FDA, warning
Mixed results from Ception, Cephalon on Cinquil
Bizjournals.com
Monday, November 23, 2009 - 9:18am
tags:
Ception Therapeutics, Cephalon, Cinquil
Merck claims win in Texas lawsuit over Vioxx
Yahoo/AP
Monday, November 23, 2009 - 9:17am
tags:
Vioxx, Texas, Merck
Boehringer’s Pradaxa Matches Warfarin as Clot Therapy in Study
Bloomberg
Monday, November 23, 2009 - 9:03am
tags:
Boehringer Ingelheim, Pradaxa, Warfarin
King May Climb as Battered Drug Companies Lure Private Equity
Bloomberg
Monday, November 23, 2009 - 9:01am
tags:
King, private equity
Germany's Merck will expand R&D in China
Yahoo/AP
Monday, November 23, 2009 - 9:00am
tags:
R&D, Merck KGaA, China
Sanofi chief lays out distinctive strategy
FT.com
Sunday, November 22, 2009 - 3:53pm
tags:
Chris Viehbacher, Sanofi, Pharma CEOs
Why J&J's Stelara Launch Should Target Dermatologists First
BNET Pharma
Sunday, November 22, 2009 - 3:52pm
tags:
JNJ, Stelara, dermatologists, psoriasis
Why Allergan and Medicis Should Embrace the "Botox Tax" in Senate Health Bill
BNET Pharma
Sunday, November 22, 2009 - 3:51pm
tags:
Allergan, Medicis, Botox, Botax bill
Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
Yahoo
Sunday, November 22, 2009 - 3:49pm
tags:
FDA, Deconsal, Cornerstone Therapeutics, warning

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.